Standard BioTools Inc. (LAB)

Paramount Global Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	158.62	166.73	51.7	81.31	28.45	68.52
Short-Term Investments	78.47	126.15	63.19	84.48	-	-
Cash & Short-Term Investments	237.09	292.87	114.9	165.78	28.45	68.52
Cash Growth	-39.93%	154.91%	-30.70%	482.70%	-58.48%	16.85%
Accounts Receivable	14.61	33.41	19.66	17.28	18.32	25.42
Other Receivables	-	0.2	-	-	-	-
Receivables	14.61	33.61	19.66	17.28	18.32	25.42
Inventory	24.17	40.74	20.53	21.47	20.83	19.69
Prepaid Expenses	7.08	8.66	3.13	4.28	4.45	4.01
Restricted Cash	-	-	-	-	0.02	0.02
Total Current Assets	506.04	375.88	158.22	208.82	72.07	117.66
Property, Plant & Equipment	47.25	71.38	54.85	59.54	65.15	55.65
Goodwill	-	111.3	106.32	106.25	106.38	106.56
Other Intangible Assets	-	28.95	1.4	13.18	29.18	42.22
Long-Term Deferred Tax Assets	-	-	-	0.23	0.18	-
Other Long-Term Assets	3.68	24.83	2.29	2.3	2.25	2.66
Total Assets	556.97	612.34	323.07	390.31	275.21	324.76
Accounts Payable	7.33	12.28	9.24	7.91	10.6	9.22
Accrued Expenses	24.21	21.61	16.09	7.52	13.59	24.01
Short-Term Debt	-	-	-	-	6.84	-
Current Portion of Long-Term Debt	-	-	59.53	2.08	-	-
Current Portion of Leases	5.09	6.23	4.32	3.68	3.05	2.97
Current Income Taxes Payable	-	-	-	1.44	-	-
Current Unearned Revenue	43.41	16.65	15.22	14.44	15.48	16.39
Other Current Liabilities	17.98	9.13	4.93	6.37	-	1.66
Total Current Liabilities	98.02	65.89	109.33	43.44	49.57	54.25
Long-Term Debt	0.3	0.3	3.98	62.81	64.21	54.22
Long-Term Leases	23.22	26.47	30.37	34.08	37.55	38.18
Long-Term Unearned Revenue	8.55	39.92	14.28	18.18	24.08	29.03
Long-Term Deferred Tax Liabilities	1.08	1.08	0.84	1.06	4.33	8.7
Other Long-Term Liabilities	1.25	6.96	1.07	0.96	0.88	1.33
Total Liabilities	132.43	140.62	159.87	160.52	180.62	185.71
Common Stock	424.54	0.4	0.08	0.08	0.08	0.08
Additional Paid-In Capital	-	1,702	860.82	847.01	831.42	815.62
Retained Earnings	-	-1,186	-1,001	-926.1	-736	-676.76
Treasury Stock	-	-46.47	-5.98	-0.56	-	-
Comprehensive Income & Other	-	1.23	-2.22	-1.9	-0.91	0.11
Total Common Equity	424.54	471.72	-148.05	-81.47	94.6	139.05
Shareholders' Equity	424.54	471.72	163.2	229.79	94.6	139.05
Total Liabilities & Equity	556.97	612.34	323.07	390.31	275.21	324.76
Total Debt	28.62	33	98.21	102.66	111.65	95.38
Net Cash (Debt)	208.47	259.88	16.69	63.13	-83.2	-26.86
Net Cash Growth	-31.46%	1457.56%	-73.57%	-	-	-
Net Cash Per Share	0.55	0.74	0.21	0.81	-1.10	-0.37
Filing Date Shares Outstanding	380.5	378.99	290.12	79.06	77.2	74.55
Total Common Shares Outstanding	380.5	377.53	80.23	79.48	76.92	74.54
Working Capital	408.01	309.99	48.89	165.37	22.5	63.41
Book Value Per Share	1.12	1.25	-1.85	-1.02	1.23	1.87
Tangible Book Value	424.54	331.47	-255.77	-200.9	-40.97	-9.74
Tangible Book Value Per Share	1.12	0.88	-3.19	-2.53	-0.53	-0.13
Buildings	-	3.48	1.76	1.71	-	-
Machinery	-	68.55	41.8	39.12	38.09	24.34
Construction In Progress	-	9.46	2.33	1.61	4.55	9.98
Leasehold Improvements	-	17.45	13.79	12.23	12.1	7.2

Updated Aug 11, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q